Hemogenyx Pharmaceuticals Plc (HEMO.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cost of Goods | 351 | 422 | 348 | 78 | N/A |
| Gross Profit | -351 | -422 | -348 | -78 | N/A |
| Operating Expenses | 1,866 | 1,249 | 1,262 | 658 | 412 |
| Operating Income | -2,216 | -1,671 | -1,610 | -736 | -412 |
| Interest Expense | 33 | 31 | 2 | 11 | N/A |
| Other Income | 155 | 214 | 90 | -1,665 | -108 |
| Pre-tax Income | -2,095 | -1,488 | -1,521 | -2,411 | -520 |
| Income Tax | 0 | -35 | -44 | -50 | 0 |
| Net Income Continuous | -2,095 | -1,453 | -1,478 | -2,362 | -520 |
| Minority Interests | 13 | 3 | N/A | N/A | N/A |
| Net Income | $-2,082 | $-1,451 | $-1,478 | $-2,362 | $-520 |
| EPS Basic Total Ops | -2.00 | -1.60 | -1.60 | -3.60 | -3.20 |
| EPS Basic Continuous Ops | -2.00 | -1.60 | -1.60 | -3.60 | -3.20 |
| EPS Diluted Total Ops | -2.00 | -1.60 | -1.60 | -3.60 | -3.20 |
| EPS Diluted Continuous Ops | -2.00 | -1.60 | -1.60 | -3.60 | -3.20 |
| EBITDA(a) | $-1,955 | $-1,362 | $-1,468 | $-2,367 | $-412 |